4587 PeptiDream Inc. |
04/05/2024 12:25 | Corporate Governance Report 5/4/2024 |
03/04/2024 08:00 | Notice of Convocation of the 18th Ordinary General Meeting of Shareholders |
02/14/2024 15:30 | Consolidated Financial Results for the Fiscal Year Ended December 31, 2023 [IFRS] |
12/19/2023 16:00 | Corporate Governance Report 19/12/2023 |
11/09/2023 15:30 | Consolidated Financial Results for the Nine Months Ended September 30, 2023 [IFRS] |
10/26/2023 16:10 | PeptiDream Announces Update on PDL1 Program Partnered with Bristol-Myers Squibb |
09/08/2023 17:00 | Payment of contingent consideration for the acquisition of the radiopharmaceutical business |
08/09/2023 15:30 | Consolidated Financial Results for the Six Months Ended June 30, 2023 [IFRS] |
05/11/2023 15:30 | Consolidated Financial Results for the Three Months Ended March 31, 2023 [IFRS] |